Breast-conservation therapy in early-stage breast cancer patients with a positive family history

Annals of Surgical Oncology

Volumn 9, Issue 9, 2002, Pages 912-919

  Vlastos, Georges ^a   Mirza, Nadeem Q ^b   Meric, Funda ^b   Hunt, Kelly K ^b   Mirza, Attiqa N ^b   Newman, Lisa A ^c   Ames, Frederick C ^b   Kuerer, Henry M ^b   Ross, Merrick I ^b   Feig, Barry ^b   Babiera, Gildy ^b   Buchholz, Thomas A ^b   Hortobagyi, Gabriel N ^b   Singletary, S Eva ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0036841067     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02557530     Document Type: Article

References (29)

1. Brody L, Biesecker BB. Breast cancer susceptibility genes: BrCal and BrCa2. Medicine 1998;77:208-26.
2. Meyn M. Ataxia. Telangiectasia, cancer, and the pathobiology of the ATM gene. Clin Genet 1999;55:289-304
3. Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H. Tumor associated with p53 germline mutations: A synopsis of 91 families. Am J Pathol 1997;150:1-13.
4. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 1997;71:800-9.
5. Lynch HT, Watson P, Conway T, et al. Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 1988;11:263-7.
6. Chaudary MA, Millis RR, Bullbrook RD, Hayward JL. Family history and bilateral breast cancer. Breast Cancer Res Treat 1985;5:201-5.
7. Easton DF, Bishop DT, Ford D, the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56:265-71.
8. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
9. Veronesi U, Salvadori B, Luini A, et al. Conservation treatment of early breast cancer: Long-term results of 1.232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 1990;211:250-9.
10. Chappuis PO, Rosenblatt J, Foulkes WD. The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 1999;10:1163-70.
11. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Ductal carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991;21:289-92.
12. Burke M-F, Allison R, Tripcony L. Conservative therapy of breast cancer in Queensland. Int J Radiat Oncol Biol Phys 1995;31:295-303.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;185:1457-1.
14. Haas JA, Schultz DJ, Peterson ME, Solin LJ. An analysis of age and family history on outcome after breast-conservation treatment: The University of Pennsylvania Experience. Cancer J Sci Am 1998;4:308-15.
15. Chabner E, Nixon A, Gelman R, et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 1998; 16:2045-51.
16. Brekelmans CTM, Voogd AC, Botke G, et al. Family history of breast cancer and local recurrence after breast-conserving therapy. Eur J Cancer 1999;35:620-6.
17. Chen LM, Mundt AJ, Powers C, Halpern HJ, Weichselbaum RR. Significance of family history in breast cancer treated with breast conservation therapy. Breast J 1996;2:238-45.
18. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow up. Int J Radiat Oncol Biol Phys 1989;17:719-25.
19. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C. I2psilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 1996;14:52-7.
20. Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer: Long term results and complications. Int J Radiat Oncol Biol Phys 1987;13:29-34.
21. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Cancer 1989;63:1912-7.
22. Harrold EV, Turner BC, Marloff ET, et al. Local recurrence in the conservatively treated breast cancer patient: A correlation with age and family history. Cancer J Sci Am 1998;4:302-7.
23. Anderson DE, Badzioch MD. Bilaterality in familial breast cancer patients. Cancer 1985;56:2092-8.
24. Fisher ER. Fisher B, Sass R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer 1984;54:3002-11.
25. Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am J Epidemiol 1992;136:937-48.
26. Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J. The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 1994;179:29-32.
27. Pierce LJ, Strawderman M, Narod SA, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 2000; 18:3360-9.
28. Robson M, Levin D, Federici M, et al. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst 1999;91:2112-7.
29. Haffty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 2002;359:1471-7.